What are the indications and dosing guidelines for adrenaline (epinephrine) infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adrenaline Infusion: Indications and Dosing Guidelines

Adrenaline infusion is indicated when multiple bolus doses fail to control severe anaphylaxis or for hypotension associated with septic shock, with dosing starting at 1-4 mcg/min for adults (titrated up to 10 mcg/min) or 0.05-2 mcg/kg/min for weight-based protocols. 1, 2

Primary Indications for Adrenaline Infusion

Anaphylaxis Requiring Continuous Support

  • Start an adrenaline infusion when several bolus doses (50 mcg IV) are required for severe hypotension or bronchospasm, as adrenaline has a short half-life. 1
  • This typically occurs after 2-3 failed intramuscular or intravenous bolus attempts in refractory anaphylaxis 1
  • The infusion provides sustained alpha-agonist activity (vasoconstriction), beta-agonist effects (inotropy and bronchodilation), and reduces further mediator release 1

Septic Shock with Persistent Hypotension

  • Adrenaline infusion is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock 2
  • Consider adding adrenaline 0.1-0.5 mcg/kg/min when norepinephrine reaches 0.25 mcg/kg/min and hypotension persists 3

Preparation and Concentration

Standard Adult Preparation

  • Add 1 mg (1 mL) of 1:1000 adrenaline to 250 mL of D5W to yield a concentration of 4.0 mcg/mL (1:250,000 solution). 1, 4
  • This preparation allows for precise titration using standard infusion equipment 1

Alternative Concentration for Anaphylaxis

  • An alternative 1:100,000 solution can be prepared by adding 1 mg adrenaline to 100 mL of saline 1, 4
  • This is infused at 30-100 mL/h (5-15 mcg/min), titrated based on clinical response 1, 4

Pediatric Preparation ("Rule of 6")

  • 0.6 × body weight (kg) = number of milligrams diluted to total 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min. 1, 4

Dosing Protocols

Adult Dosing for Anaphylaxis

  • Initial infusion rate: 1-4 mcg/min (15-60 drops per minute with microdrop apparatus) 1, 4
  • Titrate up to maximum of 10 mcg/min based on clinical response 1, 4
  • Alternative protocol: Start at 5-15 mcg/min using the 1:100,000 solution, titrating up or down depending on response or toxicity 1
  • Discontinue 30 minutes after resolution of all signs and symptoms 1

Adult Dosing for Septic Shock

  • FDA-approved range: 0.05 mcg/kg/min to 2 mcg/kg/min, titrated to achieve desired mean arterial pressure 2
  • Dilute in dextrose solution prior to infusion 2
  • Infuse into a large vein 2
  • Wean gradually when discontinuing 2

Pediatric Dosing

  • 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution up to 10 mg/min; maximum single dose 0.3 mg) 1
  • Using the "Rule of 6" preparation, 1 mL/h delivers 0.1 mcg/kg/min 1, 4

Administration Requirements

Route and Access

  • Infuse adrenaline into a large vein; central venous access is strongly preferred to minimize extravasation risk. 2, 3
  • If central access unavailable, peripheral IV can be used temporarily with strict monitoring for extravasation 4

Critical Monitoring Parameters

  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration 4, 3
  • Assess for signs of excessive vasoconstriction: cold extremities, decreased urine output 3
  • Watch for cardiac adverse effects: arrhythmias, hypertension, myocardial ischemia 2
  • Monitor for pulmonary edema, which may be fatal 2

Concurrent Fluid Resuscitation

  • Administer saline 0.9% or lactated Ringer's solution at high rate via large-bore IV cannula (large volumes may be required). 1
  • For septic shock, ensure adequate volume resuscitation before and during adrenaline administration 3
  • In anaphylaxis with hypotension, rapid infusion of 1-2 liters normal saline at 5-10 mL/kg in first 5 minutes is recommended 1

Adjunctive Medications

Secondary Management in Anaphylaxis

  • Chlorphenamine 10 mg IV (adult dose) 1
  • Hydrocortisone 200 mg IV (adult dose) 1
  • Combined H1 and H2 antagonists superior to either alone: diphenhydramine 25-50 mg IV plus ranitidine 50 mg IV 1
  • Treat persistent bronchospasm with salbutamol infusion, consider aminophylline or magnesium sulfate 1

Alternative Vasopressors for Refractory Hypotension

  • If blood pressure does not recover despite adrenaline infusion, consider metaraminol 1
  • Vasopressin and norepinephrine may be used in anaphylaxis unresponsive to epinephrine 1
  • Dopamine 2-20 mcg/kg/min may be required if epinephrine and fluid resuscitation fail 1

Critical Safety Considerations

Warnings and Precautions

  • Monitor for acute severe hypertension 2
  • Potential for serious cardiac arrhythmias and myocardial ischemia, particularly in patients with underlying heart disease 2
  • Avoid extravasation into tissues, which causes local necrosis 2
  • If extravasation occurs, infiltrate phentolamine 5-10 mg diluted in 10-15 mL saline at the site immediately 3
  • Potential for oliguria or renal impairment 2

Drug Interactions

  • Alpha blockers, vasodilators (nitrates), diuretics, antihypertensives, and ergot alkaloids counter the pressor effects 2
  • Beta blockers, tricyclic antidepressants, MAO inhibitors, and COMT inhibitors potentiate adrenaline effects 2
  • Beta blockers, halogenated anesthetics, quinidine, and cardiac glycosides increase arrhythmogenic potential 2
  • For patients on beta-blockers with refractory cardiovascular effects, glucagon 1-5 mg IV over 5 minutes followed by infusion (5-15 mg/min) may be useful 1

Common Pitfalls to Avoid

Dosing and Route Confusion

  • Never confuse anaphylaxis dosing (intramuscular boluses of 0.3-0.5 mg from 1:1000 solution) with cardiac arrest dosing (IV push of 1 mg from 1:10,000 solution). 5, 6
  • Iatrogenic overdose from administering cardiac arrest doses for anaphylaxis causes potentially lethal cardiac complications including severe systolic dysfunction 5
  • The 1:1000 concentration is for intramuscular use; 1:10,000 is for intravenous bolus use 5, 6

Premature Discontinuation

  • Do not stop infusion prematurely—continue until 30 minutes after complete resolution of symptoms 1
  • Protracted or biphasic reactions can occur; observe patients for at least 6 hours after acute event 7
  • After severe reaction, close observation for 24 hours is recommended 1

Inadequate Fluid Resuscitation

  • Failure to provide aggressive fluid resuscitation (crystalloid boluses of 20 mL/kg) alongside adrenaline infusion leads to inadequate response. 1
  • In septic shock, minimum 30 mL/kg crystalloid bolus should be administered before or concurrent with adrenaline 3

Mixing with Incompatible Solutions

  • Never mix adrenaline with sodium bicarbonate or other alkaline solutions in the IV line—adrenergic agents are inactivated in alkaline solutions. 3, 8

Post-Infusion Management

Observation and Monitoring

  • Vital signs should be monitored continuously during infusion and for extended period after discontinuation 1
  • After anaphylaxis, arrange transfer to appropriate Critical Care area 1
  • Take Mast Cell Tryptase samples: initial sample during resuscitation, second at 1-2 hours, third at 24 hours or in convalescence 1

Weaning Protocol

  • Wean adrenaline infusion gradually rather than abrupt discontinuation 2
  • Reduce infusion rate incrementally while monitoring blood pressure and clinical response 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Recognition and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anaphylaxis--recognition and management.

Australian family physician, 2012

Guideline

Epinephrine Dosing for Myocardial Infarction in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.